5.0
20 Oct 2020
Current employee
Montpellier
Recommend
CEO approval
Business outlook
Pros
Minimally invasive liver cancer treatment
Cons
Provide the next-gen robotized platformenabling advanced percutaneous therapy
Check out your Company Bowl for anonymous work chats.